Sichuan Huiyu Pharmaceutical Co Ltd Net Asset Quality Index
Sichuan Huiyu Pharmaceutical Co Ltd net asset quality index. Sichuan Huiyu Pharmaceutical Co Ltd (688553) has a Net Asset Quality Index of 76.3% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥4.88 Billion minus total liabilities of CN¥1.16 Billion yields net assets of CN¥3.72 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Sichuan Huiyu Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Sichuan Huiyu Pharmaceutical Co Ltd (2017–2024)
Net asset quality index of Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024. This chart shows how Sichuan Huiyu Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the index stands at 76.3%, representing net assets of CN¥3.72 Billion against total assets of CN¥4.88 Billion CNY. See shareholders equity of Sichuan Huiyu Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
Sichuan Huiyu Pharmaceutical Co Ltd Net Asset Quality Index by Year (2017–2024)
Sichuan Huiyu Pharmaceutical Co Ltd net asset quality index by year from 2017 to 2024. The table below presents the year-by-year Net Asset Quality Index for Sichuan Huiyu Pharmaceutical Co Ltd from 2017 to 2024, covering 8 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Sichuan Huiyu Pharmaceutical Co Ltd worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 76.9% | CN¥3.97 Billion | CN¥5.17 Billion | CN¥1.19 Billion | ▼ -3.6 pp |
| 2023 | 80.6% | CN¥3.77 Billion | CN¥4.69 Billion | CN¥911.22 Million | ▼ -6.4 pp |
| 2022 | 86.9% | CN¥3.72 Billion | CN¥4.28 Billion | CN¥558.44 Million | ▲ +0.8 pp |
| 2021 | 86.2% | CN¥3.56 Billion | CN¥4.13 Billion | CN¥571.01 Million | ▲ +24.2 pp |
| 2020 | 62.0% | CN¥751.48 Million | CN¥1.21 Billion | CN¥461.26 Million | ▲ +14.4 pp |
| 2019 | 47.5% | CN¥408.65 Million | CN¥859.98 Million | CN¥451.33 Million | ▲ +91.9 pp |
| 2018 | -44.4% | CN¥-150.70 Million | CN¥339.31 Million | CN¥490.02 Million | ▲ +33.9 pp |
| 2017 | -78.3% | CN¥-185.32 Million | CN¥236.61 Million | CN¥421.94 Million | — |